RCARRenovaCare, Inc.

About RenovaCare, Inc. (RCAR)

RenovaCare, Inc. (RCAR) is a Biotechnology company headquartered in Scottsdale, AZ, United States whose shares trade over-the-counter on the Expert Market tier.

RenovaCare, Inc. is a development-stage biotechnology and medical device company focusing on the research, development and commercialization of autologous (using a patient's own cells) cellular therapies that can be used for medical and aesthetic applications. The Company does not have any commercialized products. We are currently developing and testing the CellMist System which is a cell isolation procedure that enzymatically renders stem cells from the patients own skin or other tissues. The resulting stem cell suspension is administered topically with our SkinGun spray device as a cell therapy onto wounds, including burns, to facilitate healing. On May 6, 2021 the Food and Drug Administration gave full-approval of the Company's Investigational Device Exemption (IDE) application to proceed with initial clinical testing of the CellMist System and SkinGun spray device in adult burn patients. The clinical trial protocol is an open-label, single-arm clinical study that is enrolling 14 adult human burn subjects with partial-thickness, second-degree deep thermal burn wounds covering between 10% and 30% total body surface area. The Company may engage up to four (4) U.S. burn centers to conduct the clinical study. Currently, the clinical trial is activated, enrolling and treating patients. The CELLMIST 1 clinical study is expected to reach completion in late 2022.

Products and services

The Company does not have any commercialized products. The Company's activities have consisted principally of performing research and development activities, business development efforts, and raising capital to support such activities.

RCAR key facts

Ticker symbol

RCAR

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Scottsdale, AZ, United States

Country of incorporation

US

Year of incorporation

1983

Employees

1

Estimated market cap

$8.7K (as of Apr 16, 2025)

Shares outstanding

87,352,364

Reporting standard

Dark: Alternative Reporting Standard

Audit status

Audited

Fiscal year end

12/31

RenovaCare, Inc. leadership

• Kaiyo Nedd — President, CEO
• Harmel Singh Rayat — President, Treasurer, Secretary
• Amit Singh — VP, Investor Rel.
• Justin Frere, CPA — Consultant
• Lucy Wu — Controller

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with R